Sweden's Dedicare Q3 net sales rise 31% on acquisitions

By Reuters News


Overview

  • Sweden-based healthcare staffing firm's Q3 net sales rose 31% yr/yr, driven by acquisitions

  • EBITA and EBITA margin improved significantly from previous year

  • Acquisitions in social care made substantial contributions to sales and earnings


Outlook

  • Company says healthcare staffing market is stabilising but demand remains hesitant and competition intense

  • Dedicare says it will continue to focus on efficiency and profitability amid challenging market conditions

  • Company to prioritise development of social care operations and profitability in Denmark


Result Drivers

  • ACQUISITIONS - Co said Q3 growth and improved earnings were mainly driven by acquired operations in social care

  • EFFICIENCY MEASURES - Rationalisations and improvements in staffing business contributed to stable underlying earnings

  • ORGANIC SALES - Organic sales grew 2.1% yr/yr, though organic earnings were flat compared to previous year


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

SEK 511.70 mln

Q3 Net Income

SEK 19.50 mln

Q3 EBIT

SEK 28.80 mln

Q3 EBITA

SEK 30.90 mln

Q3 EBITA Margin

6.00%

Q3 EBIT Margin

5.60%


Analyst Coverage

  • The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 4 three months ago


Reuters Recommended Reads

  • Oct 26 - Kforce Q3 revenue rises on technology staffing, slightly beats estimates

  • Oct 27 - Sweden's Alfa Laval Q3 sales rise on order intake

  • Oct 26 - Sweden's Alleima misses Q3 revenue estimates


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk